CLINICAL_TRIALS
trial_result
· 2025-03-07
Clinical Trial Update: ATL001 in Patients With Metastatic or Recurrent Melanoma [Phase 1, Phase 2]
Summary
The ATL001 trial in metastatic or recurrent melanoma (Phase 1/2) has been terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Achilles Therapeutics UK Limited | Conditions: Melanoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-03-07